Bank Of America Corp Orgenesis Inc. Transaction History

Bank Of America Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.39 - $0.63 $102 - $166	264 Added 132.0%	464 $0
Q1 2024 May 15, 2024	SELL	$0.28 - $0.9 $10 - $32	-36 Reduced 15.25%	200 $0
Q4 2023 Feb 14, 2024	BUY	$0.44 - $0.96 $15 - $34	36 Added 18.0%	236 $0
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.44 $82 - $118	-82 Reduced 29.08%	200 $0
Q1 2023 May 12, 2023	BUY	$1.18 - $2.59 $25 - $56	22 Added 8.46%	282 $0
Q4 2022 Feb 10, 2023	SELL	$1.18 - $2.24 $337 - $640	-286 Reduced 52.38%	260 $0
Q3 2022 Nov 14, 2022	SELL	$1.38 - $2.38 $1,712 - $2,953	-1,241 Reduced 69.45%	546 $0
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.74 $3,475 - $7,221	-1,931 Reduced 51.94%	1,787 $4,000
Q1 2022 May 16, 2022	SELL	$2.31 - $3.72 $1,002 - $1,614	-434 Reduced 10.45%	3,718 $13,000
Q4 2021 Feb 08, 2022	SELL	$2.61 - $4.9 $456 - $857	-175 Reduced 4.04%	4,152 $12,000
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $9,071 - $10,727	-1,972 Reduced 31.31%	4,327 $21,000
Q2 2021 Sep 13, 2021	BUY	$4.19 - $5.88 $26,392 - $37,038	6,299 New	6,299 $32,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $32.2M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.